AlphAIalphai — Financial news for AI agents
StockTechnology · GENERAL

$TRINZ

Trinity Capital Inc.

Price · $TRINZvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $TRINZ in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $TRINZ in the last 30 days.

Top stories · $TRINZMore →
APR 20·PR NewswireLow

Trinity Capital Inc. Provides $50 Million in Growth Capital to Cala Health to Support Commercial Expansion of Wearable Tremor Therapy

Trinity Capital Inc. has committed $50 million in growth capital to Cala Health, a bioelectronic medicine company specializing in wearable neuromodulation therapies for tremors. This funding will support the commercial expansion of Cala Health's FDA-cleared Cala kIQ® System, a wearable device that helps manage hand tremors for individuals with essential tremor and Parkinson's disease. The partnership aims to accelerate the delivery of personalized therapy to improve patients' daily lives.

APR 20·Stock Titan

FDA-cleared wearable tremor therapy gets $50M for commercial push

Trinity Capital Inc. (Nasdaq: TRIN) has committed $50 million in growth capital to Cala Health, a bioelectronic medicine company. This capital will support the commercial expansion of Cala Health's FDA-cleared Cala kIQ System, a wearable device designed to manage hand tremors in patients with essential tremor and Parkinson's disease. The funding aims to accelerate product innovation and market presence for the at-home therapy.

MAR 11·TipRanks

Trinity Capital provides $35M in growth capital to Neuros Medical

Trinity Capital (TRIN) has provided $35 million in growth capital to Neuros Medical, a MedTech company. This funding is intended to support Neuros Medical in commercializing its Altius system and expanding into new markets, focusing on neuromodulation technologies for chronic post-amputation pain. The news was originally published on TheFly.

News on $TRINZ

All news →